PharmaTelevision - The Allergan Model

PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: The Allergan Model

Visitors: You are watching a 5 minute preview.

Get more information and subscribe now

RSS

Twitter

In This Episode:

Summary
Transcript
Participants
Company

Allergan is a 'restless company', according to David Pyott, its CEO, and that is what makes it an exciting and dynamic company to work for. Made famous by Botox, Allergan's roots are firmly in ophthalmology an area it continues to grow alongside its medical aesthetics, making the company a global niche player. Here, Mr Pyott describes the essence of the Allergan's business model and how he never forgets how important it is for them to be close to their customers.

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

Allergan's roots are firmly in Ophthalmology

Fintan Walton:

Hello and welcome to PharmaVentures business review here in San Francisco. On this show I have David Pyott who is CEO and Chairman of Allergan based in Irvine, California. Welcome to the show.

David Pyott:

Thank you.

Fintan Walton:

David, Allergan is a company that is probably well known for BOTOX it&s also known for its ophthalmic products, many people who have got contact lenses will do will remember Allergan as a brand name, but what is Allergan? How would you describe the Allergan Corporation?

David Pyott:

Well really Allergan is a company that concentrates on very specific medical specialties, so often the words specialty pharma is used for us and in some ways it&s appropriate although I think the other specialty pharma&s are quite different from us or we are different from them. And then we have a lot of biotech elements as well because of course BOTOX by a definition is a biotech product that is a very, very large molecule. And the other thing that&s unusual about us is that we do this pretty much on a world wide scale, so we are not just US company or just a UK company or just a European company.

Fintan Walton:

So in a sense you are a global niche player will that be a way you describe it?

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.

David Pyott

Chairman of the Board and Chief Executive Officer

Mr. Pyott, Chairman of the Board and CEO, joined Allergan as President in January 1998. Previously, he was head of the Nutrition Division and a member of the Executive Committee of Novartis AG from 1995 through 1997. Mr. Pyott has more than 23 years of international experience in nutrition and health care and has worked in Austria, Germany, the Netherlands, Spain, Switzerland, Malaysia and Singapore. Mr. Pyott holds a diploma in German and European Law from the Europa Institute at the University of Amsterdam, a Master of Arts degree from the University of Edinburgh, and a Master of Business Administration degree from the London Business School. He has also been honored in the Queen&s Birthday Honors List in 2006 and holds the title of Commander of the British Empire.

Allergan

Founded in 1950, Allergan, Inc., with headquarters in Irvine, California, is a multi-specialty health care company that discovers, develops and commercializes innovative pharmaceuticals, biologics and medical devices that enable people to live life to its greatest potential to see more clearly, move more freely, express themselves more fully. Allergan employs more than 8,500 people worldwide and operates world-class research and development facilities and state-of-the-art manufacturing plants. In addition to its discovery-to-development research programs, Allergan has global marketing and sales capabilities, with a presence in more than 100 countries.